Immunomedics (IMMU) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts IMMU Hot Sheet
Price: $87.86 --0%
Financial Fact:
Total costs and expenses: 15.69M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total costs and expenses: 15.69M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Immunomedics (NASDAQ: IMMU) reported Q2 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $700 thousand versus the consensus estimate of $1.23 million.
For earnings history and earnings-related data on Immunomedics (IMMU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- H.C. Wainwright Reiterates Buy Rating on Lifeward (LFWD)
- Lowe's (LOW) PT Lowered to $275 at Guggenheim
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
